EFFICACY AND SAFETY OF MIRIKIZUMAB AFTER 52-WEEKS MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE

Bruce E. Sands  1     William Sandborn  2     Laurent Peyrin-Biroulet  3     Peter Higgins  4     Fumihito Hirai  5     Vipul Jairath  6     Geert R. D'Haens  7     Maria T. Abreu     Ruth Belin     Elisa Gomez Valderas     Debra Miller     April Naegeli     Vipin Arora     Paul Pollack     Jay Tuttle     Toshifumi Hibi    
1 Icahn School of Medicine at Mount Sinai,New York,United States
2 University of California San Diego,La Jolla,United States
3 Nancy University Hospital Inserm U 954,Vandoeuvre les Nancy,France
4 University of Michigan,Ann Arbor,United States
5 Fukuoka University Chikushi Hospital,Chikushino,Japan
6 Western University,London,Canada
7 Univers

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing